IL1A and cryopyrin-associated periodic syndrome: Mechanistic studies in CAPS mouse models and clinical experience with IL‐1‐targeted therapies both suggest that excessive IL‐1β production is the key mediator of systemic inflammatory pathology in CAPS, with evidence for additional roles of IL‐18 and pyroptosis.18, 60, 61